Global Varicella Vaccine Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Varicella Vaccine market size is predicted to grow from US$ 4740 million in 2025 to US$ 7560 million in 2031; it is expected to grow at a CAGR of 8.1% from 2025 to 2031.
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.
Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.
LP Information, Inc. (LPI) ' newest research report, the “Varicella Vaccine Industry Forecast” looks at past sales and reviews total world Varicella Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Varicella Vaccine sales for 2025 through 2031. With Varicella Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Varicella Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Varicella Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Varicella Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Varicella Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Varicella Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Varicella Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Varicella Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Varicella Vaccine market?
What factors are driving Varicella Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Varicella Vaccine market opportunities vary by end market size?
How does Varicella Vaccine break out by Type, by Application?
The global Varicella Vaccine market size is predicted to grow from US$ 4740 million in 2025 to US$ 7560 million in 2031; it is expected to grow at a CAGR of 8.1% from 2025 to 2031.
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.
Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.
LP Information, Inc. (LPI) ' newest research report, the “Varicella Vaccine Industry Forecast” looks at past sales and reviews total world Varicella Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Varicella Vaccine sales for 2025 through 2031. With Varicella Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Varicella Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Varicella Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Varicella Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Varicella Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Varicella Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Varicella Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Varicella Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injection
- Freeze-Dried Powder
- Kids Injection
- Adults Injection
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- GSK
- Shanghai Institute
- BCHT
- Changsheng
- Keygen
- Green Cross
- Biken
What is the 10-year outlook for the global Varicella Vaccine market?
What factors are driving Varicella Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Varicella Vaccine market opportunities vary by end market size?
How does Varicella Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Varicella Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Varicella Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Varicella Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Varicella Vaccine Segment by Type
2.2.1 Injection
2.2.2 Freeze-Dried Powder
2.3 Varicella Vaccine Sales by Type
2.3.1 Global Varicella Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Varicella Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Varicella Vaccine Sale Price by Type (2020-2025)
2.4 Varicella Vaccine Segment by Application
2.4.1 Kids Injection
2.4.2 Adults Injection
2.5 Varicella Vaccine Sales by Application
2.5.1 Global Varicella Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Varicella Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Varicella Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Varicella Vaccine Breakdown Data by Company
3.1.1 Global Varicella Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Varicella Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Varicella Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Varicella Vaccine Revenue by Company (2020-2025)
3.2.2 Global Varicella Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Varicella Vaccine Sale Price by Company
3.4 Key Manufacturers Varicella Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Varicella Vaccine Product Location Distribution
3.4.2 Players Varicella Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VARICELLA VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Varicella Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Varicella Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Varicella Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Varicella Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Varicella Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Varicella Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Varicella Vaccine Sales Growth
4.4 APAC Varicella Vaccine Sales Growth
4.5 Europe Varicella Vaccine Sales Growth
4.6 Middle East & Africa Varicella Vaccine Sales Growth
5 AMERICAS
5.1 Americas Varicella Vaccine Sales by Country
5.1.1 Americas Varicella Vaccine Sales by Country (2020-2025)
5.1.2 Americas Varicella Vaccine Revenue by Country (2020-2025)
5.2 Americas Varicella Vaccine Sales by Type (2020-2025)
5.3 Americas Varicella Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Varicella Vaccine Sales by Region
6.1.1 APAC Varicella Vaccine Sales by Region (2020-2025)
6.1.2 APAC Varicella Vaccine Revenue by Region (2020-2025)
6.2 APAC Varicella Vaccine Sales by Type (2020-2025)
6.3 APAC Varicella Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Varicella Vaccine by Country
7.1.1 Europe Varicella Vaccine Sales by Country (2020-2025)
7.1.2 Europe Varicella Vaccine Revenue by Country (2020-2025)
7.2 Europe Varicella Vaccine Sales by Type (2020-2025)
7.3 Europe Varicella Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Varicella Vaccine by Country
8.1.1 Middle East & Africa Varicella Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Varicella Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Varicella Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Varicella Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Varicella Vaccine
10.3 Manufacturing Process Analysis of Varicella Vaccine
10.4 Industry Chain Structure of Varicella Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Varicella Vaccine Distributors
11.3 Varicella Vaccine Customer
12 WORLD FORECAST REVIEW FOR VARICELLA VACCINE BY GEOGRAPHIC REGION
12.1 Global Varicella Vaccine Market Size Forecast by Region
12.1.1 Global Varicella Vaccine Forecast by Region (2026-2031)
12.1.2 Global Varicella Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Varicella Vaccine Forecast by Type (2026-2031)
12.7 Global Varicella Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Varicella Vaccine Product Portfolios and Specifications
13.1.3 Merck Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Varicella Vaccine Product Portfolios and Specifications
13.2.3 GSK Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Shanghai Institute
13.3.1 Shanghai Institute Company Information
13.3.2 Shanghai Institute Varicella Vaccine Product Portfolios and Specifications
13.3.3 Shanghai Institute Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Shanghai Institute Main Business Overview
13.3.5 Shanghai Institute Latest Developments
13.4 BCHT
13.4.1 BCHT Company Information
13.4.2 BCHT Varicella Vaccine Product Portfolios and Specifications
13.4.3 BCHT Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 BCHT Main Business Overview
13.4.5 BCHT Latest Developments
13.5 Changsheng
13.5.1 Changsheng Company Information
13.5.2 Changsheng Varicella Vaccine Product Portfolios and Specifications
13.5.3 Changsheng Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Changsheng Main Business Overview
13.5.5 Changsheng Latest Developments
13.6 Keygen
13.6.1 Keygen Company Information
13.6.2 Keygen Varicella Vaccine Product Portfolios and Specifications
13.6.3 Keygen Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Keygen Main Business Overview
13.6.5 Keygen Latest Developments
13.7 Green Cross
13.7.1 Green Cross Company Information
13.7.2 Green Cross Varicella Vaccine Product Portfolios and Specifications
13.7.3 Green Cross Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Green Cross Main Business Overview
13.7.5 Green Cross Latest Developments
13.8 Biken
13.8.1 Biken Company Information
13.8.2 Biken Varicella Vaccine Product Portfolios and Specifications
13.8.3 Biken Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Biken Main Business Overview
13.8.5 Biken Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Varicella Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Varicella Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players ofFreeze-Dried Powder
Table 5. Global Varicella Vaccine Sales byType (2020-2025) & (M Doses)
Table 6. Global Varicella Vaccine Sales Market Share byType (2020-2025)
Table 7. Global Varicella Vaccine Revenue byType (2020-2025) & ($ million)
Table 8. Global Varicella Vaccine Revenue Market Share byType (2020-2025)
Table 9. Global Varicella Vaccine Sale Price byType (2020-2025) & (USD/Dose)
Table 10. Global Varicella Vaccine Sale by Application (2020-2025) & (M Doses)
Table 11. Global Varicella Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Varicella Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Varicella Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Varicella Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Varicella Vaccine Sales by Company (2020-2025) & (M Doses)
Table 16. Global Varicella Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Varicella Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Varicella Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Varicella Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Varicella Vaccine Producing Area Distribution and Sales Area
Table 21. Players Varicella Vaccine Products Offered
Table 22. Varicella Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Varicella Vaccine Sales by Geographic Region (2020-2025) & (M Doses)
Table 26. Global Varicella Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Varicella Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Varicella Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Varicella Vaccine Sales by Country/Region (2020-2025) & (M Doses)
Table 30. Global Varicella Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Varicella Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Varicella Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Varicella Vaccine Sales by Country (2020-2025) & (M Doses)
Table 34. Americas Varicella Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Varicella Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Varicella Vaccine Sales byType (2020-2025) & (M Doses)
Table 37. Americas Varicella Vaccine Sales by Application (2020-2025) & (M Doses)
Table 38. APAC Varicella Vaccine Sales by Region (2020-2025) & (M Doses)
Table 39. APAC Varicella Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Varicella Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Varicella Vaccine Sales byType (2020-2025) & (M Doses)
Table 42. APAC Varicella Vaccine Sales by Application (2020-2025) & (M Doses)
Table 43. Europe Varicella Vaccine Sales by Country (2020-2025) & (M Doses)
Table 44. Europe Varicella Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Varicella Vaccine Sales byType (2020-2025) & (M Doses)
Table 46. Europe Varicella Vaccine Sales by Application (2020-2025) & (M Doses)
Table 47. Middle East & Africa Varicella Vaccine Sales by Country (2020-2025) & (M Doses)
Table 48. Middle East & Africa Varicella Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Varicella Vaccine Sales byType (2020-2025) & (M Doses)
Table 50. Middle East & Africa Varicella Vaccine Sales by Application (2020-2025) & (M Doses)
Table 51. Key Market Drivers & Growth Opportunities of Varicella Vaccine
Table 52. Key Market Challenges & Risks of Varicella Vaccine
Table 53. Key IndustryTrends of Varicella Vaccine
Table 54. Varicella Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Varicella Vaccine Distributors List
Table 57. Varicella Vaccine Customer List
Table 58. Global Varicella Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 59. Global Varicella Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Varicella Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 61. Americas Varicella Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Varicella Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 63. APAC Varicella Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Varicella Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 65. Europe Varicella Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Varicella Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 67. Middle East & Africa Varicella Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Varicella Vaccine SalesForecast byType (2026-2031) & (M Doses)
Table 69. Global Varicella Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Varicella Vaccine SalesForecast by Application (2026-2031) & (M Doses)
Table 71. Global Varicella Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Varicella Vaccine Product Portfolios and Specifications
Table 74. Merck Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. GSK Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Varicella Vaccine Product Portfolios and Specifications
Table 79. GSK Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. Shanghai Institute Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Shanghai Institute Varicella Vaccine Product Portfolios and Specifications
Table 84. Shanghai Institute Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Shanghai Institute Main Business
Table 86. Shanghai Institute Latest Developments
Table 87. BCHT Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. BCHT Varicella Vaccine Product Portfolios and Specifications
Table 89. BCHT Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. BCHT Main Business
Table 91. BCHT Latest Developments
Table 92. Changsheng Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Changsheng Varicella Vaccine Product Portfolios and Specifications
Table 94. Changsheng Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Changsheng Main Business
Table 96. Changsheng Latest Developments
Table 97. Keygen Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Keygen Varicella Vaccine Product Portfolios and Specifications
Table 99. Keygen Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. Keygen Main Business
Table 101. Keygen Latest Developments
Table 102. Green Cross Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Green Cross Varicella Vaccine Product Portfolios and Specifications
Table 104. Green Cross Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. Green Cross Main Business
Table 106. Green Cross Latest Developments
Table 107. Biken Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Biken Varicella Vaccine Product Portfolios and Specifications
Table 109. Biken Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110. Biken Main Business
Table 111. Biken Latest Developments
LIST OFFIGURES
Figure 1. Picture of Varicella Vaccine
Figure 2. Varicella Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Varicella Vaccine Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Varicella Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Varicella Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Varicella Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Varicella Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection
Figure 12. Product Picture ofFreeze-Dried Powder
Figure 13. Global Varicella Vaccine Sales Market Share byType in 2025
Figure 14. Global Varicella Vaccine Revenue Market Share byType (2020-2025)
Figure 15. Varicella Vaccine Consumed in Kids Injection
Figure 16. Global Varicella Vaccine Market: Kids Injection (2020-2025) & (M Doses)
Figure 17. Varicella Vaccine Consumed in Adults Injection
Figure 18. Global Varicella Vaccine Market: Adults Injection (2020-2025) & (M Doses)
Figure 19. Global Varicella Vaccine Sale Market Share by Application (2024)
Figure 20. Global Varicella Vaccine Revenue Market Share by Application in 2025
Figure 21. Varicella Vaccine Sales by Company in 2025 (M Doses)
Figure 22. Global Varicella Vaccine Sales Market Share by Company in 2025
Figure 23. Varicella Vaccine Revenue by Company in 2025 ($ millions)
Figure 24. Global Varicella Vaccine Revenue Market Share by Company in 2025
Figure 25. Global Varicella Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Varicella Vaccine Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Varicella Vaccine Sales 2020-2025 (M Doses)
Figure 28. Americas Varicella Vaccine Revenue 2020-2025 ($ millions)
Figure 29. APAC Varicella Vaccine Sales 2020-2025 (M Doses)
Figure 30. APAC Varicella Vaccine Revenue 2020-2025 ($ millions)
Figure 31. Europe Varicella Vaccine Sales 2020-2025 (M Doses)
Figure 32. Europe Varicella Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Varicella Vaccine Sales 2020-2025 (M Doses)
Figure 34. Middle East & Africa Varicella Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Americas Varicella Vaccine Sales Market Share by Country in 2025
Figure 36. Americas Varicella Vaccine Revenue Market Share by Country (2020-2025)
Figure 37. Americas Varicella Vaccine Sales Market Share byType (2020-2025)
Figure 38. Americas Varicella Vaccine Sales Market Share by Application (2020-2025)
Figure 39. United States Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Varicella Vaccine Sales Market Share by Region in 2025
Figure 44. APAC Varicella Vaccine Revenue Market Share by Region (2020-2025)
Figure 45. APAC Varicella Vaccine Sales Market Share byType (2020-2025)
Figure 46. APAC Varicella Vaccine Sales Market Share by Application (2020-2025)
Figure 47. China Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. India Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Varicella Vaccine Sales Market Share by Country in 2025
Figure 55. Europe Varicella Vaccine Revenue Market Share by Country (2020-2025)
Figure 56. Europe Varicella Vaccine Sales Market Share byType (2020-2025)
Figure 57. Europe Varicella Vaccine Sales Market Share by Application (2020-2025)
Figure 58. Germany Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59.France Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Varicella Vaccine Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Varicella Vaccine Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Varicella Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Egypt Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Varicella Vaccine in 2025
Figure 72. Manufacturing Process Analysis of Varicella Vaccine
Figure 73. Industry Chain Structure of Varicella Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Varicella Vaccine Sales MarketForecast by Region (2026-2031)
Figure 76. Global Varicella Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Varicella Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Varicella Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Varicella Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Varicella Vaccine Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Varicella Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Varicella Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Varicella Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Varicella Vaccine Segment by Type
2.2.1 Injection
2.2.2 Freeze-Dried Powder
2.3 Varicella Vaccine Sales by Type
2.3.1 Global Varicella Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Varicella Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Varicella Vaccine Sale Price by Type (2020-2025)
2.4 Varicella Vaccine Segment by Application
2.4.1 Kids Injection
2.4.2 Adults Injection
2.5 Varicella Vaccine Sales by Application
2.5.1 Global Varicella Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Varicella Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Varicella Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Varicella Vaccine Breakdown Data by Company
3.1.1 Global Varicella Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Varicella Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Varicella Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Varicella Vaccine Revenue by Company (2020-2025)
3.2.2 Global Varicella Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Varicella Vaccine Sale Price by Company
3.4 Key Manufacturers Varicella Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Varicella Vaccine Product Location Distribution
3.4.2 Players Varicella Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VARICELLA VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Varicella Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Varicella Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Varicella Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Varicella Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Varicella Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Varicella Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Varicella Vaccine Sales Growth
4.4 APAC Varicella Vaccine Sales Growth
4.5 Europe Varicella Vaccine Sales Growth
4.6 Middle East & Africa Varicella Vaccine Sales Growth
5 AMERICAS
5.1 Americas Varicella Vaccine Sales by Country
5.1.1 Americas Varicella Vaccine Sales by Country (2020-2025)
5.1.2 Americas Varicella Vaccine Revenue by Country (2020-2025)
5.2 Americas Varicella Vaccine Sales by Type (2020-2025)
5.3 Americas Varicella Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Varicella Vaccine Sales by Region
6.1.1 APAC Varicella Vaccine Sales by Region (2020-2025)
6.1.2 APAC Varicella Vaccine Revenue by Region (2020-2025)
6.2 APAC Varicella Vaccine Sales by Type (2020-2025)
6.3 APAC Varicella Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Varicella Vaccine by Country
7.1.1 Europe Varicella Vaccine Sales by Country (2020-2025)
7.1.2 Europe Varicella Vaccine Revenue by Country (2020-2025)
7.2 Europe Varicella Vaccine Sales by Type (2020-2025)
7.3 Europe Varicella Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Varicella Vaccine by Country
8.1.1 Middle East & Africa Varicella Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Varicella Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Varicella Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Varicella Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Varicella Vaccine
10.3 Manufacturing Process Analysis of Varicella Vaccine
10.4 Industry Chain Structure of Varicella Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Varicella Vaccine Distributors
11.3 Varicella Vaccine Customer
12 WORLD FORECAST REVIEW FOR VARICELLA VACCINE BY GEOGRAPHIC REGION
12.1 Global Varicella Vaccine Market Size Forecast by Region
12.1.1 Global Varicella Vaccine Forecast by Region (2026-2031)
12.1.2 Global Varicella Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Varicella Vaccine Forecast by Type (2026-2031)
12.7 Global Varicella Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Varicella Vaccine Product Portfolios and Specifications
13.1.3 Merck Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Varicella Vaccine Product Portfolios and Specifications
13.2.3 GSK Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Shanghai Institute
13.3.1 Shanghai Institute Company Information
13.3.2 Shanghai Institute Varicella Vaccine Product Portfolios and Specifications
13.3.3 Shanghai Institute Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Shanghai Institute Main Business Overview
13.3.5 Shanghai Institute Latest Developments
13.4 BCHT
13.4.1 BCHT Company Information
13.4.2 BCHT Varicella Vaccine Product Portfolios and Specifications
13.4.3 BCHT Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 BCHT Main Business Overview
13.4.5 BCHT Latest Developments
13.5 Changsheng
13.5.1 Changsheng Company Information
13.5.2 Changsheng Varicella Vaccine Product Portfolios and Specifications
13.5.3 Changsheng Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Changsheng Main Business Overview
13.5.5 Changsheng Latest Developments
13.6 Keygen
13.6.1 Keygen Company Information
13.6.2 Keygen Varicella Vaccine Product Portfolios and Specifications
13.6.3 Keygen Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Keygen Main Business Overview
13.6.5 Keygen Latest Developments
13.7 Green Cross
13.7.1 Green Cross Company Information
13.7.2 Green Cross Varicella Vaccine Product Portfolios and Specifications
13.7.3 Green Cross Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Green Cross Main Business Overview
13.7.5 Green Cross Latest Developments
13.8 Biken
13.8.1 Biken Company Information
13.8.2 Biken Varicella Vaccine Product Portfolios and Specifications
13.8.3 Biken Varicella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Biken Main Business Overview
13.8.5 Biken Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Varicella Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Varicella Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players ofFreeze-Dried Powder
Table 5. Global Varicella Vaccine Sales byType (2020-2025) & (M Doses)
Table 6. Global Varicella Vaccine Sales Market Share byType (2020-2025)
Table 7. Global Varicella Vaccine Revenue byType (2020-2025) & ($ million)
Table 8. Global Varicella Vaccine Revenue Market Share byType (2020-2025)
Table 9. Global Varicella Vaccine Sale Price byType (2020-2025) & (USD/Dose)
Table 10. Global Varicella Vaccine Sale by Application (2020-2025) & (M Doses)
Table 11. Global Varicella Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Varicella Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Varicella Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Varicella Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Varicella Vaccine Sales by Company (2020-2025) & (M Doses)
Table 16. Global Varicella Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Varicella Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Varicella Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Varicella Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Varicella Vaccine Producing Area Distribution and Sales Area
Table 21. Players Varicella Vaccine Products Offered
Table 22. Varicella Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Varicella Vaccine Sales by Geographic Region (2020-2025) & (M Doses)
Table 26. Global Varicella Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Varicella Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Varicella Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Varicella Vaccine Sales by Country/Region (2020-2025) & (M Doses)
Table 30. Global Varicella Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Varicella Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Varicella Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Varicella Vaccine Sales by Country (2020-2025) & (M Doses)
Table 34. Americas Varicella Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Varicella Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Varicella Vaccine Sales byType (2020-2025) & (M Doses)
Table 37. Americas Varicella Vaccine Sales by Application (2020-2025) & (M Doses)
Table 38. APAC Varicella Vaccine Sales by Region (2020-2025) & (M Doses)
Table 39. APAC Varicella Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Varicella Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Varicella Vaccine Sales byType (2020-2025) & (M Doses)
Table 42. APAC Varicella Vaccine Sales by Application (2020-2025) & (M Doses)
Table 43. Europe Varicella Vaccine Sales by Country (2020-2025) & (M Doses)
Table 44. Europe Varicella Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Varicella Vaccine Sales byType (2020-2025) & (M Doses)
Table 46. Europe Varicella Vaccine Sales by Application (2020-2025) & (M Doses)
Table 47. Middle East & Africa Varicella Vaccine Sales by Country (2020-2025) & (M Doses)
Table 48. Middle East & Africa Varicella Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Varicella Vaccine Sales byType (2020-2025) & (M Doses)
Table 50. Middle East & Africa Varicella Vaccine Sales by Application (2020-2025) & (M Doses)
Table 51. Key Market Drivers & Growth Opportunities of Varicella Vaccine
Table 52. Key Market Challenges & Risks of Varicella Vaccine
Table 53. Key IndustryTrends of Varicella Vaccine
Table 54. Varicella Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Varicella Vaccine Distributors List
Table 57. Varicella Vaccine Customer List
Table 58. Global Varicella Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 59. Global Varicella Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Varicella Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 61. Americas Varicella Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Varicella Vaccine SalesForecast by Region (2026-2031) & (M Doses)
Table 63. APAC Varicella Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Varicella Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 65. Europe Varicella Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Varicella Vaccine SalesForecast by Country (2026-2031) & (M Doses)
Table 67. Middle East & Africa Varicella Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Varicella Vaccine SalesForecast byType (2026-2031) & (M Doses)
Table 69. Global Varicella Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Varicella Vaccine SalesForecast by Application (2026-2031) & (M Doses)
Table 71. Global Varicella Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Varicella Vaccine Product Portfolios and Specifications
Table 74. Merck Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. GSK Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Varicella Vaccine Product Portfolios and Specifications
Table 79. GSK Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. Shanghai Institute Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Shanghai Institute Varicella Vaccine Product Portfolios and Specifications
Table 84. Shanghai Institute Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Shanghai Institute Main Business
Table 86. Shanghai Institute Latest Developments
Table 87. BCHT Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. BCHT Varicella Vaccine Product Portfolios and Specifications
Table 89. BCHT Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. BCHT Main Business
Table 91. BCHT Latest Developments
Table 92. Changsheng Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Changsheng Varicella Vaccine Product Portfolios and Specifications
Table 94. Changsheng Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Changsheng Main Business
Table 96. Changsheng Latest Developments
Table 97. Keygen Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Keygen Varicella Vaccine Product Portfolios and Specifications
Table 99. Keygen Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. Keygen Main Business
Table 101. Keygen Latest Developments
Table 102. Green Cross Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Green Cross Varicella Vaccine Product Portfolios and Specifications
Table 104. Green Cross Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. Green Cross Main Business
Table 106. Green Cross Latest Developments
Table 107. Biken Basic Information, Varicella Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Biken Varicella Vaccine Product Portfolios and Specifications
Table 109. Biken Varicella Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 110. Biken Main Business
Table 111. Biken Latest Developments
LIST OFFIGURES
Figure 1. Picture of Varicella Vaccine
Figure 2. Varicella Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Varicella Vaccine Sales Growth Rate 2020-2031 (M Doses)
Figure 7. Global Varicella Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Varicella Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Varicella Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Varicella Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection
Figure 12. Product Picture ofFreeze-Dried Powder
Figure 13. Global Varicella Vaccine Sales Market Share byType in 2025
Figure 14. Global Varicella Vaccine Revenue Market Share byType (2020-2025)
Figure 15. Varicella Vaccine Consumed in Kids Injection
Figure 16. Global Varicella Vaccine Market: Kids Injection (2020-2025) & (M Doses)
Figure 17. Varicella Vaccine Consumed in Adults Injection
Figure 18. Global Varicella Vaccine Market: Adults Injection (2020-2025) & (M Doses)
Figure 19. Global Varicella Vaccine Sale Market Share by Application (2024)
Figure 20. Global Varicella Vaccine Revenue Market Share by Application in 2025
Figure 21. Varicella Vaccine Sales by Company in 2025 (M Doses)
Figure 22. Global Varicella Vaccine Sales Market Share by Company in 2025
Figure 23. Varicella Vaccine Revenue by Company in 2025 ($ millions)
Figure 24. Global Varicella Vaccine Revenue Market Share by Company in 2025
Figure 25. Global Varicella Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Varicella Vaccine Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Varicella Vaccine Sales 2020-2025 (M Doses)
Figure 28. Americas Varicella Vaccine Revenue 2020-2025 ($ millions)
Figure 29. APAC Varicella Vaccine Sales 2020-2025 (M Doses)
Figure 30. APAC Varicella Vaccine Revenue 2020-2025 ($ millions)
Figure 31. Europe Varicella Vaccine Sales 2020-2025 (M Doses)
Figure 32. Europe Varicella Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Varicella Vaccine Sales 2020-2025 (M Doses)
Figure 34. Middle East & Africa Varicella Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Americas Varicella Vaccine Sales Market Share by Country in 2025
Figure 36. Americas Varicella Vaccine Revenue Market Share by Country (2020-2025)
Figure 37. Americas Varicella Vaccine Sales Market Share byType (2020-2025)
Figure 38. Americas Varicella Vaccine Sales Market Share by Application (2020-2025)
Figure 39. United States Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Varicella Vaccine Sales Market Share by Region in 2025
Figure 44. APAC Varicella Vaccine Revenue Market Share by Region (2020-2025)
Figure 45. APAC Varicella Vaccine Sales Market Share byType (2020-2025)
Figure 46. APAC Varicella Vaccine Sales Market Share by Application (2020-2025)
Figure 47. China Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. India Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Varicella Vaccine Sales Market Share by Country in 2025
Figure 55. Europe Varicella Vaccine Revenue Market Share by Country (2020-2025)
Figure 56. Europe Varicella Vaccine Sales Market Share byType (2020-2025)
Figure 57. Europe Varicella Vaccine Sales Market Share by Application (2020-2025)
Figure 58. Germany Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59.France Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Varicella Vaccine Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Varicella Vaccine Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Varicella Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Egypt Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Varicella Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Varicella Vaccine in 2025
Figure 72. Manufacturing Process Analysis of Varicella Vaccine
Figure 73. Industry Chain Structure of Varicella Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Varicella Vaccine Sales MarketForecast by Region (2026-2031)
Figure 76. Global Varicella Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Varicella Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Varicella Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Varicella Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Varicella Vaccine Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Deferiprone Market Growth 2025-2031
US$ 3,660.00
March 2025
83 pages
Global Darbepoetin Alfa Market Growth 2025-2031
US$ 3,660.00
January 2025
75 pages
Global Malignant Glioma Therapeutics Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
85 pages
Global Pets Internal Medicine Market Growth 2025-2031
US$ 3,660.00
December 2025
100 pages
